Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects

Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure

(2012) Stefano Lunghetti et al.   Cardiology Journal

Pharmacogenetics and personalized medicine

(2012) A. Li-Wan-Po   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Cardioprotection: chances and challenges of its translation to the clinic

(2012) Gerd Heusch   LANCET

Levosimendan attenuates pulmonary vascular remodeling

(2011) M. Revermann et al.   INTENSIVE CARE MEDICINE

Newer Inotropes in Pediatric Heart Failure

(2011) Timothy M Hoffman   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Erratum to “Pro/Anti-Inflammatory Cytokine Imbalance in Postischemic Left Ventricular Remodeling”

(2011) Anna Laura Pasqui et al.   MEDIATORS OF INFLAMMATION

Old and New Intravenous Inotropic Agents in the Treatment of Advanced Heart Failure

(2011) Marco Metra et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Oral levosimendan improves filling pressure and systolic function during long-term treatment

(2011) Mikko Jalanko et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury

(2010) Anna B Roehl et al.   BMC Neurology

Inotropes in cardiac patients: update 2011

(2010) John T Parissis et al.   Current Opinion in Critical Care

A structural and functional perspective into the mechanism of Ca2+-sensitizers that target the cardiac troponin complex

(2010) Ian M. Robertson et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Acetylation status does not affect levosimendan's hemodynamic effects in heart failure patients

(2010) Matti Kivikko et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial KATPchannel

(2009) E Grossini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE†

(2009) Alexandre Mebazaa et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic Implications of Baroreflex Sensitivity in Heart Failure Patients in the Beta-Blocking Era

(2009) Maria Teresa La Rovere et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart Failure

(2009) Alain Cohen-Solal et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Levosimendan on Left Ventricular Relaxation and Early Filling at Maintained Preload and Afterload Conditions After Aortic Valve Replacement for Aortic Stenosis

(2008) Kirsten Jörgensen et al.   CIRCULATION

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

(2008) et al.   EUROPEAN HEART JOURNAL

Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure

(2008) Kati H. Miettinen et al.   EUROPEAN JOURNAL OF HEART FAILURE

Levosimendan: from basic science to clinical practice

(2008) John T. Parissis et al.   HEART FAILURE REVIEWS

Pharmacokinetics of Intravenous Levosimendan and Its Metabolites in Subjects With Hepatic Impairment

(2008) Jaakko Puttonen et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs

(2007) Patricia N. Banfor et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure

(2007) John T. Parissis et al.   ATHEROSCLEROSIS